The Impact of Preoperative Weight Loss on Long-term Success: 5-year Outcomes After Metabolic Bariatric Surgery

• by Kayleigh A. M. van Dam, Cathelijne Kam, Marijn T. F. Jense, Geert H. J. M. Verkoulen, Pieter P. H. L. Broos, Evelien de Witte, Jan Willem M. Greve, Evert-Jan G. Boerma

• January 6, 2026

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

• by Kathryn Wighton

• May 14, 2026

• 6 min

A temporally Anchored Retrieval-Augmented Generation Framework for Metabolic and Bariatric Surgery Patient Education: An IFSO Artificial Intelligence Task Force Multinational Validation Study

• by Yash Kumar Atri, Tom Hartvigsen, Yung Lee, Allan Okrainec, Mohammad Kermansaravi, Shahab Shahabi, Silvia Leite, Mary O’Kane, Ricardo Cohen, Thomas H. Shin

• May 20, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min